TITLE

Reaction to D-penicillamine in rheumatoid arthritis

AUTHOR(S)
Day, A T; Golding, J R
PUB. DATE
September 1973
SOURCE
British Medical Journal;9/15/1973, Vol. 3 Issue 5880, p593
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
64108263

 

Related Articles

  • Adverse reactions to D-penicillamine after gold toxicity. Dodd, M.J.; Griffiths, I.D.; Thompson, M. // British Medical Journal;6/21/1980, Vol. 280 Issue 6230, p1498 

    Investigates the adverse reaction to D-penicillamine of patients with rheumatoid arthritis. Comparison of the reactions to gold; Effectiveness of D-penicillamine and gold against rheumatoid arthritis; Influence of gold for the development of reactions to D-penicillamine.

  • Auranofin or D-Penicillamine in the Treatment of Rheumatoid Arthritis. Hochberg, Marc C. // Annals of Internal Medicine;Oct86, Vol. 105 Issue 4, p528 

    Presents a study which compared the effectiveness of auranofin and d-penicillamine in the treatment of rheumatoid arthritis. Patients and methods; Results; Discussion.

  • Toxicity of D-penicillamine in rheumatoid arthritis. O'Brien, William M.; O'Brien, W M // Annals of Internal Medicine;Jan80, Vol. 92 Issue 1, p120 

    Reveals that D-Penicillamine is effective in treating rheumatoid arthritis with visceral involvement. Diseases associated with small immunoglobulins that are described as complications of D-penicillamine therapy; Percentage of patients on penicillamine who developed some signs of renal...

  • Pemphigus Vulgaris Associated with Rheumatoid Arthritis in a Patient not Taking Penicillamine. Gholizadeh, Narges; Zenouz, Ali Taghavi; Eslami, Hossein // Journal of Dental Research, Dental Clinics, Dental Prospects;2012, Vol. 6 Issue 1, p33 

    D-penicillamine is one of the disease-modifying anti-rheumatic drugs (DMARDs). Drug-induced pemphigus is not frequently associated with D-penicillamine, and to date, the number of reported cases is about a hundred. Most reports of D-penicillamine-induced pemphigus vulgaris are in patients with...

  • D-Penicillamine-induced myasthenia gravis in rheumatoid arthritis. Gordon, Robert A.; Burnside, John W.; Gordon, R A; Burnside, J W // Annals of Internal Medicine;Nov77, Vol. 87 Issue 5, p578 

    Presents a case study of a patient who developed myasthenia gravis while being treated with D-penicillamine for rheumatoid arthritis. Medical history of the patient; Results of laboratory examinations; Outcome of the treatment.

  • LETTERS. Christensson, Tony; Cucher, Bobb G.; Ballou, Stanley P.; Khan, Muhammad Asim; Kushner, Irving; Oreopoulos, D.G.; Husdan, H.; Leung, M.; Reid, D.B.W.; Rapoport, A. // Annals of Internal Medicine;Nov76, Vol. 85 Issue 5, p614 

    Discusses several issues on medical care and internal medicine. Prevalence of familial primary hyperparathyroidism; Therapeutic use of D-penicillamine for active rheumatoid arthritis; Diffuse intervertebral disk calcification in primary amyloidosis.

  • Wilson's disease masquerading as rheumatoid arthritis. Kumar, Rahul; Anandh K.; Goel, Sonal // Indian Journal of Medical Specialities;Jan-Mar2015, Vol. 6 Issue 1, p33 

    The article presents a case study of a 26-year-old woman with rheumatoid arthritis and later diagnosis of Wilson's disease and her treatment with zinc and D-penicillamine therapy and also discusses the pathophysiology underlying arthritis in patients with Wilson's disease.

  • Adverse effects of D-penicillamine in rheumatoid arthritis. Stein, Howard B.; Patterson, A. Caroline; Offer, Robert C.; Atkins, Christopher J.; Teufel, Alvena; Robinson, Harold S.; Stein, H B; Patterson, A C; Offer, R C; Atkins, C J; Teufel, A; Robinson, H S // Annals of Internal Medicine;Jan80, Vol. 92 Issue 1, p24 

    Adverse effects to D-penicillamine were studied prospectively over 3 years in 259 patients with rheumatoid arthritis. Ninety-five percent had had gold therapy previously, yet 70% benefited from D-penicillamine therapy. Of the 275 courses given, 160 (58%) were complicated by at least one...

  • Pseudoxanthoma elasticum-like skin changes induced by pecnicillamine. Thomas, R. H. Meyrick; Light, N.; Avery, N. C.; Stephens, A. D.; Kirby, J. D. T. // Journal of the Royal Society of Medicine;Sep1984, Vol. 77 Issue 9, p794 

    The article presents the case of a patient who developed penicillamine dermopathy following high-dose D-penicillamine therapy for cystinuria. The patient who is a 59-year-old man was diagnosed as having cystinuria at the age of 37 years. D-penicillamine is used for the treatment of rheumatoid...

  • Rheumatoid arthritis.  // GP: General Practitioner;5/27/2002, p73 

    Presents a clinical review of rheumatoid arthritis. Epidemiology of rheumatoid arthritis; Therapeutics for rheumatoid arthritis; Causal factor of rheumatoid arthritis.

Share

Other Topics